We are pleased to announce that ReachBio will be exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 56th Annual Meeting in Baltimore, Maryland. Our booth, number 1616, will display a range of customizable cell-based contract assay services for life science and pharmaceutical organizations worldwide. We will also be displaying our new cellPrism® drug development platform that offers a broad spectrum of toxicology and immunology assays to help address your labs program challenges. Since the year 2007, we have worked with over 200 different companies to advance their understanding of the potency, efficacy and toxicity of their leading candidate therapies. Furthermore, our Chief Scientific Office and Lab Manager will be involved in a poster presentation that was done in collaboration with the scientific team at Synthon Biopharmaceuticals.
“An Ex Vivo Flow Cytometry Platform to Evaluate the Effects of Compounds on Lymphotoxicity in Multiple Species”
Date: March 16, 2017
Abstract: #3292, Poster: #261
“Impurity Qualification Strategy for the Cytostatic Clofarabine”
H. van der Woude1, A. Sesink1, T. van Achterberg1, E. Clarke2, and D. van den Dobbelsteen1.
1 Synthon Biopharmaceuticals B.V., Nijmegen, Netherlands and 2 ReachBio Research Labs, Seattle, WA.
Date: March 14, 2017
Author Attended: 11:15AM - 12:45PM
Abstract: #1697, Poster: #149
This annual event takes place at the centrally located Baltimore Convention Center and all attendees must provide a badge for entrance. Attending this event allows our team to attend the plenary lectures, scientific session, receptions as well as explore the charming seaside city of Baltimore. Additionally we appreciate the in person moments, conversations, and dinners that we get to share with our colleagues and clients. We look forward to seeing you in Baltimore!